Agency Information Collection Activities: Proposed Collection; Comment Request
| Published date | 16 July 2021 |
| Citation | 86 FR 37756 |
| Record Number | 2021-15099 |
| Section | Notices |
| Court | Centers For Medicare & Medicaid Services,Health And Human Services Department |
37756
Federal Register / Vol. 86, No. 134 / Friday, July 16, 2021 / Notices
property was no longer available for
long-term leasing. CDC attempted to
purchase the underlying property on
which LLEM is located, but NIOSH
vacated the LLEM after market-based
purchase offers were rejected by the
property owners.
In 2013, CDC completed a Project
Development Study to outline a design
solution to replace the LLEM. The study
presented the facility and site
requirements and design concepts for
the replacement facilities. In 2016, to
identify potentially available locations
that could accommodate the space
requirements defined in the 2013 study,
GSA issued (on behalf of CDC) two
separate Requests for Expressions of
Interest (REOI) for a site, developed or
undeveloped, that could be used for the
new underground safety research
facility. The first REOI, advertised in
June 2016, contained a limited
delineated area within a 200-mile radius
of the LLEM. The REOI set forth criteria
that would be used to evaluate the
suitability of the submitted sites. One
expression of interest that had the
potential to meet the minimum criteria
was received. After further evaluation,
however, the site was found to be non-
viable.
The second REOI was issued in
October 2016 and expanded the
delineated area to the entire contiguous
United States. Three expressions of
interest were received for sites in
Kentucky, Missouri, and West Virginia.
The Kentucky site did not meet the
minimum criteria, and the Missouri site
expression of interest did not contain all
necessary information to evaluate. The
offeror of the Missouri site did not
respond to subsequent GSA inquiries.
The potential site in West Virginia
met the minimum criteria and was
determined to be a viable site. The site
is located near Mace, West Virginia, and
straddles the Randolph and Pocahontas
County lines.
In accordance with NEPA, as
implemented by the CEQ regulations (40
CFR parts 1500–1508), with GSA as a
cooperating agency, CDC prepared a
Draft EIS for the proposed acquisition of
the Site and construction of a new
underground safety research facility on
the Site. Under NEPA, federal agencies
are required to evaluate the
environmental effects of their proposed
actions and a range of reasonable
alternatives to the proposed action
before making a decision. On February
14, 2019, in accordance with NEPA,
CDC published a Notice of Availability
announcing that a Draft EIS for the
proposed acquisition and development
had been prepared. The Draft EIS
evaluated two alternatives: The
Proposed Action Alternative
(acquisition of the Site and construction
of a new underground safety research
facility) and the No Action Alternative.
No other alternatives were considered
because only one qualifying site was
identified through the site selection
process discussed above.
Publication of the Draft EIS notice
initiated a 51-day review period, which
ended on April 5, 2019. During this
period, CDC received comments from
government agencies, a Native
American tribe, and the public. These
comments pertained to the proposed
action in general, including the purpose
and need; water quality/groundwater
impacts; traffic impacts; tourism
impacts; noise and vibration impacts;
viewshed impacts; and wildlife impacts.
All comments were considered when
preparing the Final EIS and responses to
the comments are provided in the Final
EIS. The Final EIS identifies the
Proposed Action Alternative as CDC’s
Preferred Alternative.
CDC will make a decision on whether
to proceed with the Proposed Action on
or after August 16, 2021. At that time,
CDC will issue a Record of Decision
documenting and explaining its
decision based on the Final EIS.
Dated: July 13, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2021–15139 Filed 7–15–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10768]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY
: Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION
: Notice.
SUMMARY
: The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES
: Comments must be received by
September 14, 2021.
ADDRESSES
: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to http://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRA-
Listing.html.
FOR FURTHER INFORMATION CONTACT
:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION
:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES
).
CMS–10768—The ESRD Network Peer
Mentoring Program
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
VerDate Sep<11>2014 17:26 Jul 15, 2021 Jkt 253001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1
jbell on DSKJLSW7X2PROD with NOTICES
37757
Federal Register / Vol. 86, No. 134 / Friday, July 16, 2021 / Notices
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: The ESRD
Network Peer Mentoring Program; Use:
The End Stage Renal Disease (ESRD)
Network Peer Mentoring Program is a
voluntary program designed to provide
patient peer support to people with
kidney disease. In part, the peer support
is beneficial because patients can give
each other something most practitioners
do not have: Lived experience with
kidney disease. The support and
perspective of someone who has ‘‘been
there’’ can help people better cope with
their circumstances.
The ESRD Network Peer Mentoring
Program is a partnership between
dialysis facilities, ESRD Networks, and
patient peer mentors and mentees that
wish to engage in the program. The peer
mentoring program is organized and
published with educational
opportunities for peer mentors and
mentees, provides resources, and
includes a complementary toolkit for
ESRD Networks and dialysis facilities to
promote and operationalize the
program.
Program applicants are people with
ESRD who: (1) Are adults over the age
of 18; have been receiving in-center or
home dialysis or have been transplanted
for at least six months; actively engage
in the care plan; consistently
demonstrate leadership qualities at
facility Quality Assurance &
Performance Improvement (QAPI)
meetings, Lobby Days, and other facility
activities; and wish to be a peer mentor;
or (2) are over 18 years of age; are newly
diagnosed patients but have been on in-
center dialysis for at least six months;
are looking for peer support to help
them transition to their new reality; and
are known as a peer mentee.
To participate in the ESRD Network
Peer Mentoring Program, peer mentors
and mentees will complete an online
application form stored in Confluence.
The application serves to validate the
peer mentor or peer mentee interest in
the ESRD Network Peer Mentoring
Program. Information collection is
important to the process of pairing peer
mentors and mentees with similarly
lived experience and interests with their
kidney disease. In addition, the
application collects information about
the peers’ interest in kidney disease,
treatment modality, age range, preferred
gender recognition, and attitudes toward
their kidney disease diagnosis. It also
supports aligning hobbies, and genders
to support best matched peers with each
other. Form Number: CMS–10768 (OMB
control number: 0938–NEW);
Frequency: Once; Affected Public:
Individuals and Households; Number of
Respondents: 75; Total Annual
Responses: 75; Total Annual Hours: 19.
(For policy questions regarding this
collection, contact Lisa Rees at 816–
426–6353.)
Dated: July 12, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–15099 Filed 7–15–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Best Practices for Advancing Cultural
Competency, Language Access and
Sensitivity Toward Asian Americans
and Pacific Islanders
AGENCY
: Office of Minority Health,
Department of Health and Human
Services (HHS).
ACTION
: Request for information.
SUMMARY
: The U.S. Department of
Health and Human Services (HHS)
Office of Minority Health (OMH) seeks
input from Asian American and Pacific
Islander (AAPI) communities and AAPI-
serving organizations to inform the
development of guidance describing
best practices for advancing cultural
competency, language access, and
sensitivity toward Asian Americans and
Pacific Islanders in the context of the
Federal Government’s COVID–19
response. This is NOT a solicitation for
proposals or proposal abstracts.
Please note: This request is for
information (RFI) and is for planning
purposes only. It is not a notice for a
proposal and does not commit the
federal government to issue a
solicitation, make an award, or pay any
costs associated with responding to this
announcement. All submitted
information shall remain with the
federal government and will not be
returned. All responses will become
part of the public record and will not be
held confidential. The federal
government reserves the right to use
information provided by respondents
for purposes deemed necessary and
legally appropriate. Respondents are
advised that the federal government is
under no obligation to acknowledge
receipt of the information received or
provide feedback to respondents with
respect to any information submitted.
Responses will not be accepted after the
due date. After a review of the responses
received, a notice of funding
opportunity or pre-solicitation synopsis
and solicitation may be published.
DATES
: To be assured consideration in
the development of best practices
guidance, written comments must be
submitted and received at the address
provided below, no later than 11:59
p.m. on August 17, 2021.
ADDRESSES
: OMH invites the
submission of the requested information
through one of the following methods:
•Preferred method: Submit
information through the Federal
eRulemaking Portal at http://
www.regulations.gov. Follow the online
instructions for submissions.
•Email: Send comments to
minorityhealth@hhs.gov with the
subject line ‘‘OMH RFI: AAPI Best
Practices.’’
Submissions received after the
deadline will not be reviewed. Respond
concisely and in plain language. You
may use any structure or layout that
presents your information well. You
may respond to some or all of our
questions, and you can suggest other
factors or relevant questions. You may
also include links to online material or
interactive presentations. Clearly mark
any proprietary information and place it
in its own section or file. Your response
will become government property, and
we may publish some of its non-
proprietary content.
FOR FURTHER INFORMATION CONTACT
:
Juliet Bui, 1101 Wootton Parkway, Suite
100, Rockville, MD, 20852, (240) 453–
6166, Juliet.Bui@hhs.gov.
SUPPLEMENTARY INFORMATION
:
I. Background Information
On January 26, 2021, President Biden
issued a Memorandum Condemning and
Combating Racism, Xenophobia, and
Intolerance against Asian Americans
and Pacific Islanders in the United
States. The memorandum directed the
HHS Secretary, in coordination with the
COVID–19 Health Equity Task Force, to
VerDate Sep<11>2014 17:26 Jul 15, 2021 Jkt 253001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1
jbell on DSKJLSW7X2PROD with NOTICES
